In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir-Reference-Cited by-同舟云学术

In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir

Published:2017-09-20 Issue:12 Volume:83 Page:2789-2797
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Bastiaans Diane E. T.¹^ORCID,Immohr Laura I.²,Zeinstra Gertrude G.³,Strik‐Albers Riet⁴,Pein‐Hackelbusch Miriam⁵,Flier Michiel⁴,Haan Anton F. J.⁶,Boelens Jaap Jan⁷,Lankester Arjan C.⁸,Burger David M.¹^ORCID,Warris Adilia⁹

Affiliation:

1. Department of PharmacyRadboud University Medical Center Nijmegen The Netherlands

2. Institute of Pharmaceutics and BiopharmaceuticsHeinrich‐Heine‐University Düsseldorf Germany

3. Consumer Science & HealthWageningen UR Food & Biobased Research Wageningen The Netherlands

4. Department of Paediatrics and Radboud Institute Molecular Life SciencesRadboud University Medical Center Nijmegen The Netherlands

5. Life Science TechnologiesUniversity of Applied Sciences Ostwestfalen‐Lippe Detmold Germany

6. Department for Health EvidenceRadboud University Medical Center Nijmegen The Netherlands

7. Department of Paediatrics, Paediatric Blood and Marrow Transplantation ProgramUniversity Medical Center Utrecht The Netherlands

8. Department of PaediatricsLeiden University Medical Center Leiden The Netherlands

9. Institute of Medical Sciences, Infection, Immunity and Inflammation Research Group; Aberdeen Fungal GroupUniversity of Aberdeen UK

Funder

ZonMw

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13396

Reference34 articles.

1. Paediatric and geriatric drug delivery

2. European Medicines Agency.Reflection paper: Formulations of choice for the paediatric population (EMEA/CHMP/PEG/194810/2005). London 28 July2006. Contract No.: EMEA/CHMP/PEG/194810/2005.

3. European Medicines Agency.Guideline on pharmaceutical development of medicines for paediatric use (EMA/CHMP/QWP/805880/2012 Rev. 2).2014. Contract No.: EMA/CHMP/QWP/805880/2012 Rev. 2.

4. Paediatric Regulation (Regulation (EC) No. 1901/2006);European Parliament and the Council;Off J Eur Union,2006

5. Regulatory perspectives on acceptability testing of dosage forms in children

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Development of a Chocolate-Based Chewable Tablet of Prednisolone—Enhancing the Palatability of Steroids for Pediatric Use;Pharmaceutics;2024-08-21

2. Palatability and Stability Studies to Optimize a Carvedilol Oral Liquid Formulation for Pediatric Use;Pharmaceutics;2023-12-25

3. Development of taste-masking microcapsules containing azithromycin by fluid bed coating for powder for suspension and in vivo evaluation;Journal of Microencapsulation;2023-05-13

4. TESTING SUITABILITY OF SWEETENERS IN MASKING THE TASTE OF LEVOCETIRIZINE DIHYDROCHLORIDE USING THE ELECTRONIC TONGUE METHOD;FARMACIA;2022-10-26

5. Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update;Pharmaceutics;2022-05-10